Technological developments in the pharmaceutical and biotech industry are reflected in increased funding, higher R&D productivity and more product launches. However, the...
08.05.2014
- A Pharma Veteran's View - Dr. John L. LaMattina is the former Senior Vice President of Pfizer, and President, Pfizer Global Research and Development. In this role, Dr. LaMattina...
12.06.2013
- Ashland today announced plans to expand its pharmaceutical research and development Center of Excellence at the Ashland Research Center in Wilmington. Ashland will be expanding its...
06.06.2013
- Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...
29.05.2013
- GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for €250 million ($321 million) - the latest bolt-on biotech buy...
23.05.2013
- Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a new type of treatment for patients with depression that have failed to benefit from standard...
23.05.2013
- Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the...
22.05.2013
- The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The...
